• References

    Clinical trials sites in the United States for Ixiaro in children under 17. Centers for Disease Control and Prevention website. Available at Accessed November 19, 2013.

    Dubischar-Kastner K, Kaltenboeck A, et al. Safety
    analysis of a Vero cell culture-derived Japanese encephalitis vaccine, IXIARO
    (IC51), in 6 months of follow-up.

    Fischer M, Lindsey N, et al; Centers for Disease Control and
    Prevention (CDC). Japanese encephalitis vaccines: recommendations of the Advisory
    Committee on Immunization Practices (ACIP).
    MMWR Recomm Rep.

    Halstead SB, Thomas SJ. New Japanese encephalitis vaccines: alternatives to production in mouse brain.
    Expert Rev Vaccines. 2011;10(3):355-364.

    Halstead SB, Thomas SJ. Japanese encephalitis: new options for active
    Clin Infect Dis.

    Japanese encephalitis. EBSCO DynaMed website. Available at: Updated May 22, 2013. Accessed November 19, 2013.

    Japanese encephalitis vaccine: What you need to know. Centers for Disease Control and Prevention website. Available at: Updated December 7, 2011. Accessed November 19, 2013.

    Lehtinen VA, Huhtamo E, Siikamäki H, Vapalahti O. Japanese encephalitis in a Finnish traveler on a two-week holiday in Thailand.
    J Clin Virol. 2008;43(1):93-95.

    Wilder-Smith A, Halstead SB. Japanese encephalitis: update on vaccines and
    vaccine recommendations.
    Curr Opin Infect Dis.